Lisa Nelson

CEO at Scientia Clinical Research Ltd

Speaker

Lisa Nelson has over 35 years of experience within the Australian early phase ecosystem, with broad and diverse exposure to the pharmaceutical industry in parallel.

A leader in her field, Lisa is the CEO of Scientia Clinical Research: the first purpose built Phase I unit, and first in patient early phase clinical trial facility in NSW.

Integral to her success has been Lisa’s knowledge and experience in establishing and managing multiple globally recognised Phase I units in other Australian states, as well as her track record and history of creating new business opportunities, developing key client relationships and keeping abreast of developments in early phase drug and device research.

Lisa's knowledge, experience and track record of success can help sponsors simplify their early phase clinical trials and accelerate early phase development.